CHAT Protein
<div class="infobox infobox-protein">
| Property | Value |
|----------|-------|
| Protein Name | Choline Acetyltransferase |
| Gene | CHAT |
| UniProt ID | P21908 |
| Molecular Weight | ~82 kDa (human) |
| Subcellular Localization | Cytoplasm of cholinergic neurons |
| Protein Family | Carnitine/choline acetyltransferase family |
| Tissue Expression | Cholinergic neurons (brain, spinal cord, periphery) |
</div>
Overview
Choline acetyltransferase (CHAT) is the enzyme that synthesizes the neurotransmitter acetylcholine (ACh) from choline and acetyl-CoA[@misawa2011]. It is the definitive marker for cholinergic neurons—cells that use acetylcholine as their primary neurotransmitter. CHAT is essential for cholinergic signaling throughout the nervous system, including in brain regions critical for memory and attention (basal forebrain), motor control (brainstem and spinal cord), and autonomic function.
The cholinergic system is prominently affected in Alzheimer's disease, where CHAT activity is dramatically reduced in the basal forebrain and cortex. This loss underlies the cognitive deficits characteristic of AD and has driven the development of cholinesterase inhibitor drugs (donepezil, rivastigmine, galantamine) as symptomatic treatments[@obrien2023].
Structure and Function
Protein Structure
CHAT has a characteristic enzyme architecture[@misawa2011]:
...CHAT Protein
<div class="infobox infobox-protein">
| Property | Value |
|----------|-------|
| Protein Name | Choline Acetyltransferase |
| Gene | CHAT |
| UniProt ID | P21908 |
| Molecular Weight | ~82 kDa (human) |
| Subcellular Localization | Cytoplasm of cholinergic neurons |
| Protein Family | Carnitine/choline acetyltransferase family |
| Tissue Expression | Cholinergic neurons (brain, spinal cord, periphery) |
</div>
Overview
Choline acetyltransferase (CHAT) is the enzyme that synthesizes the neurotransmitter acetylcholine (ACh) from choline and acetyl-CoA[@misawa2011]. It is the definitive marker for cholinergic neurons—cells that use acetylcholine as their primary neurotransmitter. CHAT is essential for cholinergic signaling throughout the nervous system, including in brain regions critical for memory and attention (basal forebrain), motor control (brainstem and spinal cord), and autonomic function.
The cholinergic system is prominently affected in Alzheimer's disease, where CHAT activity is dramatically reduced in the basal forebrain and cortex. This loss underlies the cognitive deficits characteristic of AD and has driven the development of cholinesterase inhibitor drugs (donepezil, rivastigmine, galantamine) as symptomatic treatments[@obrien2023].
Structure and Function
Protein Structure
CHAT has a characteristic enzyme architecture[@misawa2011]:
N-terminal region: Contains subcellular targeting signals
Catalytic core: ~400 amino acids forming the active site
C-terminal domain: Regulatory elements and dimerization interfaceThe enzyme is organized as a homodimer, with each subunit containing distinct substrate-binding sites for choline and acetyl-CoA.
Catalytic Mechanism
CHAT catalyzes a simple transfer reaction:
Choline + Acetyl-CoA → Acetylcholine + CoA
The reaction proceeds through a ternary complex mechanism:
Choline binds to CHAT
Acetyl-CoA binds
Acetyl group transfers to choline
Acetylcholine and CoA are releasedRegulation
CHAT activity is regulated at multiple levels:
| Regulatory Mechanism | Effect |
|---------------------|--------|
| Transcriptional control | Cell-type specific expression |
| Alternative splicing | Multiple isoforms with different properties |
| Post-translational modification | Phosphorylation affects activity |
| Product inhibition | Acetylcholine feedback |
Normal Biological Function
Acetylcholine Synthesis
CHAT is the sole enzyme for ACh biosynthesis:
Substrate uptake: Choline is imported via high-affinity transporters
Acetyl-CoA source: Mitochondrial metabolism supplies acetyl groups
Vesicular packaging: Synthesized ACh is packaged into vesicles by VAChTCholinergic Neurons
CHAT defines the cholinergic system:
Basal forebrain: Projections to cortex and hippocampus (memory/attention)
Brainstem: Pedunculopontine/laterodorsal nuclei (arousal, REM sleep)
Spinal cord: Motor neurons and interneurons (motor control)
Peripheral: Autonomic preganglionic neurons, neuromuscular junctionRegional Specialization
Different CHAT isoforms are expressed in:
- Brain: Neuronal isoforms with high catalytic efficiency
- Muscle: Alternative splicing generates tissue-specific forms
Role in Neurodegeneration
Alzheimer's Disease
CHAT loss is a hallmark of AD pathophysiology[@obrien2023]:
Cholinergic Degeneration:
- Basal forebrain cholinergic neurons degenerate early
- CHAT activity reduced by 60-90% in AD cortex
- Loss correlates with cognitive deficits
Pathogenic Mechanisms:
- Amyloid pathology directly damages cholinergic neurons
- Tau pathology in basal forebrain
- Neuroinflammation contributes to neuron loss
Diagnostic Significance:
- CHAT activity in CSF may reflect cholinergic integrity
- PET ligands for cholinergic terminals in development
Parkinson's Disease
CHAT alterations in PD include:
Cortical cholinergic dysfunction: Related to cognitive impairment
Non-motor symptoms: Cholinergic deficits contribute to dementia
Treatment overlap: Cholinesterase inhibitors used for PD dementiaOther Conditions
| Disorder | CHAT Involvement |
|----------|------------------|
| DLB | Severe cholinergic loss |
| MCI | Early cholinergic changes |
| Myasthenia gravis | Autoantibodies affect function |
| ALS | Motor neuron cholinergic changes |
Therapeutic Implications
Current Treatments
Cholinesterase inhibitors are standard AD therapy[@hampel2018]:
| Drug | Mechanism | Status |
|------|-----------|--------|
| Donepezil | AChE inhibition | Approved |
| Rivastigmine | AChE/BChE inhibition | Approved |
| Galantamine | AChE modulation | Approved |
These drugs increase synaptic acetylcholine by inhibiting its breakdown, partially compensating for CHAT loss.
Emerging Strategies
| Strategy | Approach | Status |
|----------|----------|--------|
| CHAT gene therapy | Restore CHAT expression | Preclinical |
| Acetylcholine receptor agonists | Direct receptor activation | Various |
| Neurotrophic factors | Support cholinergic neurons | Research |
Biomarker Potential
CHAT-related biomarkers:
- CSF CHAT activity: May reflect cholinergic neuron health
- Imaging: Cholinergic terminal density markers
Key Publications
[Misawa H, et al. (2011) Choline acetyltransferase. Journal of Neurochemistry](https://pubmed.ncbi.nlm.nih.gov/21495839/)
[O'Brien M, et al. (2023) Cholinergic neurons in AD. Nature Reviews Neurology](https://pubmed.ncbi.nlm.nih.gov/37452156/)
[Hampel H, et al. (2018) Cholinergic system in AD therapy. Drug Discovery Today](https://pubmed.ncbi.nlm.nih.gov/29626556/)Cross-References
- [CHAT Gene](/genes/chat) — Gene encoding CHAT
- [Acetylcholine](/entities/acetylcholine) — The neurotransmitter
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease
- [Parkinson's Disease](/diseases/parkinsons-disease) — Related disease
- [Cholinergic System](/topics/cholinergic-system) — Neural system
See Also
- [Basal Forebrain](/brain-regions/basal-forebrain)
- [Acetylcholinesterase](/topics/acetylcholinesterase)
- [Cholinesterase Inhibitors](/topics/cholinesterase-inhibitors)
References
hampel2018, Cholinergic system: emerging targets for AD therapy (2018)
misawa2011, Choline acetyltransferase and acetylcholine (2011)
obrien2023, Cholinergic neurons in AD and cholinergic therapies (2023)